Literature DB >> 29089101

A novel 18-bp in-frame deletion mutation in RUNX2 causes cleidocranial dysplasia.

Li Zeng1, Jiahui Wei1, Na Zhao1, Shichen Sun1, Yixiang Wang2, Hailan Feng3.   

Abstract

OBJECTIVES: Runt-related transcription factor 2 (RUNX2) gene is known to cause rare autosomal dominant skeletal disorder Cleidocranial dysplasia (CCD). Here, we explored a novel, large deletion in RUNX2 gene in a Chinese patient with CCD and the function associated with the mutation.
DESIGN: Genomic DNA was extracted from the peripheral blood and subjected to do DNA sequencing. Sanger sequencing was used to do mutational analysis of the RUNX2 gene. Function associated with RUNX2 mutation was investigated by performing conservation analysis, secondary structure analysis, subcellular localization study and reporter assay.
RESULTS: We identified a novel, large deletion mutation involving a c.243-260delGGCGGCTGCGGCGGCGGC mutation in exon 2 of the RUNX2 gene. Conservation and secondary structure analysis revealed that the novel mutation located in QA domain and converted the structure of RUNX2. Subcellular localization analysis revealed that the novel mutant showed the same intracellular localization with the wild type of RUNX2, and both of them localized exclusively in the nucleus. While reporter assay indicated the novel mutant severely impaired the transactivation activities of RUNX2 gene.
CONCLUSIONS: Our findings demonstrated that the novel c.243-260delGGCGGCTGCGGCGGCGGC mutation resulted in CCD. These results extend the spectrum of RUNX2 mutations in CCD patients and suggest a functional role of the novel mutation in CCD.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cleidocranial dysplasia; Functional analysis; Novel mutation; RUNX2

Mesh:

Substances:

Year:  2017        PMID: 29089101     DOI: 10.1016/j.archoralbio.2017.10.020

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  5 in total

1.  Gain-of-function variants and overexpression of RUNX2 in patients with nonsyndromic midline craniosynostosis.

Authors:  Araceli Cuellar; Krithi Bala; Lorena Di Pietro; Marta Barba; Garima Yagnik; Jia Lie Liu; Christina Stevens; David J Hur; Roxann G Ingersoll; Cristina M Justice; Hicham Drissi; Jinoh Kim; Wanda Lattanzi; Simeon A Boyadjiev
Journal:  Bone       Date:  2020-04-30       Impact factor: 4.398

2.  Identification a novel de novo RUNX2 frameshift mutation associated with cleidocranial dysplasia.

Authors:  Lei Gong; Bekzod Odilov; Feng Han; Fuqiang Liu; Yujing Sun; Ningxin Zhang; Xiaolin Zuo; Jiaojiao Yang; Shouyu Wang; Xinguo Hou; Jianmin Ren
Journal:  Genes Genomics       Date:  2022-03-02       Impact factor: 2.164

3.  A Novel 90-kbp Deletion of RUNX2 Associated with Cleidocranial Dysplasia.

Authors:  Yanli Zhang; Xiaohong Duan
Journal:  Genes (Basel)       Date:  2022-06-23       Impact factor: 4.141

4.  Identification of RUNX2 variants associated with cleidocranial dysplasia.

Authors:  Xueren Gao; Kunxia Li; Yanjie Fan; Yu Sun; Xiaomei Luo; Lili Wang; Huili Liu; Zhuwen Gong; Jianguo Wang; Yu Wang; Xuefan Gu; Yongguo Yu
Journal:  Hereditas       Date:  2019-09-16       Impact factor: 3.271

5.  Glucose-induced microRNA-218 suppresses the proliferation and promotes the apoptosis of human retinal pigment epithelium cells by targeting RUNX2.

Authors:  Rui Yao; Xiaoxi Yao; Ru Liu; Jingli Peng; Tao Tian
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.